Skip to main content

Personalized Medicine Gets Boost With New Prostate Cancer Finding

In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures.

Republish
Lead image for this article

In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures. That discovery means patients may get more customized treatment plans that will try to tackle their subtype. It’s another step toward personalized medicine and a shift from a one-size-fits-all treatment approach. (The Washington Post)




Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Yes, I'll donate today

Information about the authors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics